IRIS
SONVICO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.364
EU - Europa 4.162
AS - Asia 1.801
OC - Oceania 18
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 7
Totale 10.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.305
CN - Cina 1.401
IE - Irlanda 1.079
SE - Svezia 812
FI - Finlandia 653
IT - Italia 575
UA - Ucraina 365
DE - Germania 347
TR - Turchia 221
FR - Francia 99
GB - Regno Unito 68
CA - Canada 57
AT - Austria 49
VN - Vietnam 47
IN - India 46
SG - Singapore 39
BE - Belgio 26
NL - Olanda 26
ES - Italia 16
AU - Australia 14
EU - Europa 13
CZ - Repubblica Ceca 12
JP - Giappone 11
HK - Hong Kong 10
BR - Brasile 8
IL - Israele 6
PK - Pakistan 5
PT - Portogallo 5
AR - Argentina 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
RO - Romania 4
RU - Federazione Russa 4
BG - Bulgaria 3
DK - Danimarca 3
KR - Corea 3
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
HR - Croazia 2
LU - Lussemburgo 2
MY - Malesia 2
PL - Polonia 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
BD - Bangladesh 1
BT - Bhutan 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
IR - Iran 1
MD - Moldavia 1
MX - Messico 1
NG - Nigeria 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 10.380
Salva come PNG Salva come JPEG
Città #
Dublin 1.065
Chandler 914
Jacksonville 431
Ashburn 376
Beijing 329
Dearborn 326
Ann Arbor 324
Nanjing 222
Parma 207
Izmir 184
Princeton 179
Wilmington 121
San Mateo 94
Shanghai 91
Helsinki 83
Bremen 81
Shenyang 74
Nanchang 72
Woodbridge 70
New York 61
Hebei 58
Hefei 57
Seattle 57
Des Moines 55
Kunming 55
Dong Ket 47
Jiaxing 47
Toronto 47
Guangzhou 45
Los Angeles 45
Jinan 42
Vienna 41
Houston 38
Milan 35
Boardman 34
Changsha 34
Fremont 31
Tianjin 30
Shenzhen 29
Brussels 25
Pune 25
Rome 24
Falls Church 23
Grafing 23
Norwalk 22
Konyaalti 21
Bologna 20
Zhengzhou 18
Ningbo 16
Kocaeli 13
Groningen 12
Hangzhou 12
Reggio Emilia 12
Fairfield 10
Fuzhou 10
Segrate 10
Sydney 10
London 9
Wenzhou 9
Ardea 8
Chicago 8
Santiago De Compostela 8
Taizhou 8
Mestre 7
Redwood City 7
Taiyuan 7
Washington 7
Amsterdam 6
Chengdu 6
Haikou 6
Padova 6
Strasbourg 6
Auburn Hills 5
Brescia 5
Düsseldorf 5
Edinburgh 5
Montegaldella 5
Naples 5
Ottawa 5
Stockholm 5
Wuhan 5
Xian 5
Brno 4
Cantù 4
Chongqing 4
Ferrara 4
Frankfurt am Main 4
Modena 4
Montréal 4
Multan 4
Redmond 4
Rockville 4
Tel Aviv 4
Trezzano Sul Naviglio 4
Adelaide 3
Auckland 3
Baotou 3
Borås 3
Catania 3
Collecchio 3
Totale 6.661
Salva come PNG Salva come JPEG
Nome #
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 141
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 131
MULTILAYERED PHARMACEUTICAL FORMULATION 117
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 106
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 105
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery 100
Opportunity and challenges of nasal powders: Drug formulation and delivery 98
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 95
Identifying contact-mediated, localized toxic effects of MWCNT aggregates on epithelial monolayers: A single-cell monitoring toxicity assay 95
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 95
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 93
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 89
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 87
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 87
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 86
Mechanisms of formation and disintegration of alginate beads obtained by prilling 85
Les formes pharmaceutiques du futur 85
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 82
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 82
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 80
IN13 Backscattering Spectrometer at ILL: Looking for Motions in Macromolecules and Organisms 78
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 77
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 77
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 77
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 77
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 76
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 75
Assemblage of novel release modules for the development of adaptable drug delivery systems 74
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 74
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 73
Flexibility and drug release features of lipid/saccharide nanoparticles 73
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 73
Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye 73
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 73
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 72
Dynamics of water and small molecules in bioadhesive polymer films 72
Mean square hydrogen fluctuations in chitosan/lecithin nanoparticles from elastic neutron scattering experiments 71
Sprayable pharmaceutical compositions comprising sucralfate gel for treating skin or mucosa lesions 71
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products 71
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 71
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 71
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 70
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 69
Opportunities and Challenges for the Nasal Administration of Nanoemulsions 69
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 69
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 69
New modules, new assembly kits and new assembles for controlled release of substances 68
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 68
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 68
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 67
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 67
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 67
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 66
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 66
Brain distribution of ribavirin after intranasal administration 65
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 65
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 64
Le Basi del Calcolo Farmaceutico 64
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 64
Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid 64
Biohadesive sucralfate gel based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 63
Intrapleural application of polymeric films containing cisplatin and pemetrexed in a rat tumour model of malignant pleural mesothelioma 63
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 63
Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa 62
Modular systems fitted together for the controlled release of substances 61
Assembled modules technology for site-specific prolonged delivery of norfloxacin 61
Biological In Vitro Models for Absorption by Nonoral Routes 60
The development of amikacin dry powder for pulmonary administration 60
Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin 60
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate 60
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 60
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 60
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 59
High Respirable Insulin Dry Powder for Pulmonary Administration 59
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 59
Water diffusivity in PVA-based transdermal patches 58
Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration 58
Cell penetrating peptides in ocular drug delivery: State of the art 58
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 57
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 57
Single layer transdermal film containing lidocaine: water and lidocaine mobility determined using neutron scattering 57
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 57
Establishment of an in vitro model expressing the folate receptor for the investigation of targeted delivery systems 56
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 56
Nasal Powders of Morphine Microcrystal Agglomerates 56
Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin 56
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 56
Investigation of the swelling behavior of Dome Matrix drug delivery modules by high-resolution X-ray computed tomography 55
Development and validation of a RP-HPLC method for the simultaneous detection and quantification of simvastatin's isoforms and coenzyme Q10 in lecithin/chitosan nanoparticles 55
Swellable and rigid matrices: Controlled Release Matrices with Cellulose Ethers 55
Particles and powders: Tools of innovation for non-invasive drug administration 55
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 55
Lecithin/Chitosan-based Nanoparticles for the Nasal Delivery of Statins: Enzyme-Trigger Controlled Release and Cellular Transport 55
A consensus research agenda for optimising nasal drug delivery 54
chimerical agglomerates of microparticles for nasal administration of analgesic drug powders 54
Nanostructures for overcoming the pulmonary barrier: drug delivery strategies 53
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 53
Novel Platforms for Oral Drug Delivery 52
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction 52
Lecithin/Chitosan Based Nanosystem for Tamoxifen Citrate Oral Delivery 52
Totale 7.049
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019315 0 0 0 0 0 0 0 0 0 0 241 74
2019/20202.037 340 349 104 60 151 255 262 57 163 154 37 105
2020/20211.085 22 114 93 37 122 60 130 35 218 50 129 75
2021/2022979 24 36 19 66 45 61 98 103 50 71 55 351
2022/20233.549 367 386 220 258 287 361 37 259 1.192 31 107 44
2023/20241.296 86 129 40 62 115 359 222 126 47 100 10 0
Totale 10.710